Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat

Transplantation

Volumn 64, Issue 3, 1997, Pages 391-398

  Lautenschlager, Irmeli ^a   Soots, Anu ^a   Krogerus, Leena ^a   Kauppinen, Harri ^a   Saarinen, Osmo ^a   Bruggeman, Cathrien ^b   Ahonen, Juhani ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION BIOPSY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; LYMPHOCYTOSIS; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; RENOVASCULAR DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; AZATHIOPRINE; BIOPSY, NEEDLE; CHRONIC DISEASE; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MALE; METHYLPREDNISOLONE; RATS; RATS, INBRED BN; RATS, INBRED STRAINS;

EID: 0030807628     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199708150-00003     Document Type: Article

References (41)

1. Opelz G, for the Collaborative Transplant Study. Strength of HLA-A, HLA-B and HLA-DR mismatches in relation to short- and long-term kidney graft survival. Transpl Int 1991; 4 (suppl 1): S621.
2. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
3. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993.
4. Häyry P, Isoniemi H, Yilmaz S, et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33.
5. Isoniemi H, Nurminen M, Tikkanen M, et al. Risk factors predicting chronic rejection of renal allograft. Transplantation 1994; 57: 68.
6. Matas A. Chronic rejection in renal transplant recipients: risk factors and correlates. Clin Transplant 1994; 8: 332.
7. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
8. O'Grady JG, Alexander GJ, Sutherland S, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent cofactors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 1988; ii: 302.
9. Richardson WP, Colvin BB, Cheeseman SH, et al. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 1981; 305: 57.
10. Boyce NW, Hayes K, Gee D, et al. Cytomegalovirus infection complicating renal transplantation and its relationship to acute transplant glomerulopathy. Transplantation 1988; 45: 706.
11. Lopez C, Simmons RL, Mauer SM, Najarian JS, Good RA. Association of renal allograft rejection with virus infections. Am J Med 1974; 56: 280.
12. Von Willebrand E, Pettersson E, Ahonen J, Häyry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986; 42: 364.
13. Bosch FH, Hoitsma AJ, Janssen HP, Van Loon AM, Koene RA. Cytomegalovirus infections and disease in renal transplant patients treated with cyclosporine. Transpl Int 1989; 2: 92.
14. Pouteil-Noble C, Ecochard R, Landrivon G, et al. Cytomegalovirus infection: an etiologic factor for rejection. Transplantation 1993; 55: 851.
15. Reinke P, Fiestze E, Ode-Hakim S, et al. Late renal acute allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344: 1737.
16. Lemström K, Bruning J, Bruggeman C, Lautenschlager I, Häyry P. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest 1993; 92: 549.
17. Mihatsch MJ, Ryffel B, Gudat F. The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int 1995; 48 (suppl 52): S63.
18. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
19. Paul LC. Functional and histologic characteristics of chronic renal allograft rejection. Clin Transplant 1994; 8: 319.
20. Hancock WH, Whitley WD, Tullius SG, et al. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993; 56: 643.
21. Häyry P, von Willebrand E. Transplant aspiration cytology. Transplantation 1984; 38: 7.
22. Von Willebrand E, Lautenschlager I. Fine needle aspiration cytology in kidney, liver and pancreas allografts. In: Solez K, Racusen LC, Billinham M, eds. Pathology and rejection diagnosis in solid organ transplantation. New York: Marcel Dekker, 1996: 303.
23. Lee S. An improved technique of renal transplantation in the rat. Surgery 1967; 61: 771.
24. Bruggeman C, Meijer H, Bosman F, Van Boven C. Biology of rat cytomegalovirus infection. Intervirology 1985; 24: 1.
25. Soots A, Saarinen O, Lautenschlager I, Ahonen J. Ultrasound and fine-needle aspiration biopsy in the monitoring of rat kidney allografts. Transplant Proc 1995; 27: 3559.
26. Bruning JH, Debie WHM, Dormans PHJ, Meijer H, Bruggeman CA. The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch Virol 1987; 94: 55.
27. Yilmaz S, Häyry P. The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 1993; 56: 1153.
28. Mackenzie HS, Tullius SG, Heemann UW, et al. Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest 1994; 94: 2148.
29. Coffman TM, Sanfilippo FP, Brazy PC, Yarger WE, Klotman PE. Bilateral native nephrectomy improves renal isograft function in rats. Kidney Int 1986; 30: 22.
30. Ustinov J, Loginov R, Mattila P, et al. Cytomegalovirus infection in human kidney cells in vitro. Kidney Int 1991; 40: 954.
31. Ustinov J, Loginov R, Bruggeman C, Suni J, Häyry P, Lautenschlager I. CMV-induced class II antigen expression in various rat organs. Transpl Int 1994; 7: 302.
32. Steinhoff G, You X-M, Steinmüller C, et al. Induction of endothelial adhesion molecules by rat cytomegalovirus in allogenic lung transplantation in the rat. Scand J Infect Dis Suppl 1995; 99: 58.
33. Yilmaz S, Koskinen P, Kallio E, Bruggeman C, Häyry P, Lemström K. Cytomegalovirus infection enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Kidney Int 1996; 50: 526.
34. Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature 1988; 331: 269.
35. Fujinami RS, Nelson JA, Walker L, Oldstone MBA. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR β chain: a means for graft rejection and immunosuppression. J Virol 1988; 62: 100.
36. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection: an undefined conundrum. Transplantation 1991; 52: 389.
37. Paul LC, Fellström B. Chronic rejection of the heart and kidney: have rational treatment options emerged? Transplantation 1992; 53: 1169.
38. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17.
39. Tumilowicz JJ, Gawlik ME, Bowell PP, Trentin JJ. Replication of cytomegalovirus in human arterial smooth muscle cells. J Virol 1985; 56: 839.
40. Hendrix MGR, Daemen M, Bruggeman CA. Cytomegalovirus nucleic acids distribution within the human vascular three. Am J Pathol 1991; 138: 563.
41. Span AHM, Grauls G, Bosman F, van Boven CPA, Bruggeman CA. Cytomegalovirus infection induces vascular wall injury in the rat. Atherosclerosis 1992; 93: 41.